Sun, 20 Jul 2025

 

His Excellency, Peter Obi to Deliver Keynote Address at NAPPSA's 19th Annual Conference
 
From: CEOAFRICA REPORTER
Sat, 19 Jul 2025   ||   Nigeria,
 

His Excellency, Mr Peter Obi, a prominent figure in Nigeria's political landscape, is set to deliver the keynote address at the Nigerian Association of Pharmacists and Pharmaceutical Scientists in the Americas Inc. (NAPPSA) 19th Annual Conference & Exposition. The event, scheduled for September 26, 2025, will take place at Sheraton Suites Chicago O'Hare, located at 6501 N. Mannheim Road, Rosemont, IL 60018.

This annual gathering, running from September 25 to 28, aims to bring together thought leaders and professionals in the pharmaceutical field to discuss innovative solutions in the industry. This year’s theme, "Harnessing Artificial Intelligence in Pharmaceutical Development and Healthcare Delivery," highlights the critical role that technology plays in the future of healthcare.

Emmanuel C. Ezirim, President of NAPPSA, expressed enthusiasm for Mr. Obi's participation, stating, "We are honored to have His Excellency deliver the keynote address. His extensive experience in governance, business, and advocacy for quality healthcare makes him an ideal speaker for this year’s theme. The insights he brings will undoubtedly inspire professionals in attendance and drive impactful discussions on the integration of AI in our practices."

The conference will feature a series of workshops, panel discussions, and networking opportunities, allowing participants to engage with experts in the field and explore the latest advancements in pharmaceutical science. With AI increasingly shaping the landscape of healthcare delivery, this year’s theme emphasizes the importance of adapting and integrating new technologies to enhance patient outcomes.

Attendees can look forward to an enriching experience as they embark on this journey of knowledge sharing, collaboration, and innovation. The presence of Mr. Peter Obi as keynote speaker is a testament to NAPPSA's commitment to promoting excellence and advancement in pharmaceutical sciences.

 

Tag(s):
 
 
Back to News